CONMED Corporation (CNMD) Earnings History
Elite Compounder36 years of earnings data (1990–2025) · 5-year EPS CAGR exceeds 18% — top-tier earnings quality
Loading earnings history...
CONMED Corporation (CNMD) Earnings Overview
As of June 22, 2026, CONMED Corporation (CNMD) reported trailing twelve-month net income of $55M, reflecting -64.6% year-over-year growth. The company earned $1.79 per diluted share over the past four quarters, with a net profit margin of 3.4%.
Looking at the long-term picture, CNMD's 5-year EPS compound annual growth rate (CAGR) stands at +36.4%, indicating exceptional earnings growth. The company achieved its highest annual net income of $132M in fiscal 2024.
CONMED Corporation maintains positive profitability with a gross margin of 52.8%, operating margin of 10.3%, and net margin of 3.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including HOLX ($544M net income, 13.8% margin), ATRC (-$5M net income, -2.1% margin), NVCR (-$173M net income, -20.8% margin), CNMD has room to improve margins relative to the peer group. Compare CNMD vs HOLX →
CNMD Earnings vs Peers
Earnings metrics vs comparable public companies
CNMD Historical Earnings Data (1990–2025)
36 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $47M | -64.5% | $141M | $1.51 | 3.4% | 10.3% |
| 2024 | $132M | +105.4% | $200M | $4.26 | 10.1% | 15.3% |
| 2023 | $64M | +180.0% | $121M | $2.04 | 5.2% | 9.7% |
| 2022 | -$81M | -228.8% | $70M | $-2.68 | -7.7% | 6.7% |
| 2021 | $63M | +557.2% | $110M | $1.94 | 6.2% | 10.9% |
| 2020 | $10M | -66.7% | $46M | $0.32 | 1.1% | 5.3% |
| 2019 | $29M | -29.9% | $79M | $0.97 | 3.0% | 8.3% |
| 2018 | $41M | -26.4% | $71M | $1.41 | 4.8% | 8.3% |
| 2017 | $55M | +278.4% | $47M | $1.97 | 7.0% | 5.9% |
| 2016 | $15M | -51.9% | $38M | $0.52 | 1.9% | 4.9% |
| 2015 | $30M | -5.3% | $51M | $1.09 | 4.2% | 7.1% |
| 2014 | $32M | -10.4% | $53M | $1.16 | 4.4% | 7.2% |
| 2013 | $36M | -11.2% | $57M | $1.28 | 4.7% | 7.5% |
| 2012 | $40M | +5283.1% | $65M | $1.41 | 5.3% | 8.5% |
| 2011 | $752,000 | -97.5% | $8M | $0.03 | 0.1% | 1.1% |
| 2010 | $30M | +150.0% | $57M | $1.05 | 4.3% | 8.0% |
| 2009 | $12M | -72.8% | $28M | $0.42 | 1.7% | 4.1% |
| 2008 | $45M | +7.5% | $75M | $1.52 | 6.0% | 10.1% |
| 2007 | $41M | +431.5% | $81M | $1.43 | 6.0% | 11.7% |
| 2006 | -$13M | -139.1% | -$5M | $-0.45 | -1.9% | -0.7% |
| 2005 | $32M | -4.4% | $64M | $1.08 | 5.2% | 10.3% |
| 2004 | $33M | +4.3% | $63M | $1.11 | 6.0% | 11.3% |
| 2003 | $32M | -6.1% | $80M | $1.10 | 6.5% | 16.1% |
| 2002 | $34M | +39.9% | $79M | $1.23 | 7.5% | 17.5% |
| 2001 | $24M | +26.4% | $69M | $1.00 | 5.7% | 16.1% |
| 2000 | $19M | -29.0% | $64M | $0.83 | 4.9% | 16.4% |
| 1999 | $27M | +52.8% | $75M | $1.17 | 7.3% | 20.1% |
| 1998 | $18M | +350.7% | $61M | $0.77 | 5.3% | 18.2% |
| 1997 | -$7M | -143.6% | $26M | $-0.31 | -5.1% | 18.7% |
| 1996 | $16M | +49.5% | $26M | $0.75 | 13.0% | 20.4% |
| 1995 | $11M | +101.9% | $19M | $0.63 | 10.9% | 18.9% |
| 1994 | $5M | +485.7% | $9M | $0.37 | 7.6% | 12.5% |
| 1993 | -$1M | -134.1% | -$2M | $-0.11 | -2.6% | -3.5% |
| 1992 | $4M | +5.1% | $6M | $0.28 | 9.6% | 13.6% |
| 1991 | $4M | +62.5% | $6M | $0.31 | 10.1% | 15.8% |
| 1990 | $2M | - | $4M | $0.25 | 7.6% | 14.0% |
Download Data
Export CNMD earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
36+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CNMD — Frequently Asked Questions
Quick answers to the most common questions about buying CNMD stock.
What is CNMD earnings per share (EPS)?
CNMD trailing twelve-month (TTM) diluted EPS is $1.79, reflecting -64.6% year-over-year growth. The 5-year EPS CAGR is +36.4%. Complete EPS history from 1990 to 2025 is available in the table on this page.
What is CONMED Corporation's net income?
CONMED Corporation (CNMD) trailing twelve-month net income is $55M as of 2025. Earnings declined -64.6% year-over-year. CONMED Corporation has been profitable for 3 consecutive years.
Is CNMD profitable?
Yes, CNMD is profitable with a TTM net income of $55M and a net profit margin of +3.4%. CONMED Corporation has generated profits for 3 consecutive years.
What is CNMD's earnings growth rate?
CNMD compound annual EPS growth rates (CAGR): 1-Year: -64.6%, 3-Year: N/A, 5-Year: +36.4%, 10-Year: +3.3%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1990 to 2025.
What are CNMD's profit margins?
CONMED Corporation net profit margin is +3.4%, operating margin is +10.3%, and gross margin is +52.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is +4.7%.
Is CNMD growing earnings?
CNMD earnings are declining — EPS fell -64.6% year-over-year. TTM net income dropped to $55M. This contrasts with the 5-year CAGR of +36.4%.
What was CNMD's best earnings year?
CONMED Corporation's highest annual net income on record is $132M, achieved in fiscal year 2024. Earnings history on this page spans 1990 to 2025 and includes all annual and quarterly figures.
What were CNMD's earnings last quarter?
CNMD's most recent reported quarter was Q1 2026. Net income was $14M with diluted EPS of $0.45. For a full breakdown of all quarters, see the quarterly earnings table on this page.